OCT 19, 2021 5:00 AM PDT

Air Surveillance Technology Sniffs Out Coronaviruses in the Room

WRITTEN BY: Tara Fernandez

Imagine walking into a party where people were socializing (unmasked) in a confined space. With the ongoing pandemic not showing signs of backing down, this may ring alarm bells for some, particularly the unvaccinated or those with underlying health issues.

What if a device could sample the air in the room and alert if SARS-CoV-2 was detected?

Research by engineers from Nanyang Technological University in Singapore could mean that such monitoring technology could soon become a reality.

In a study featured in the journal Indoor Air, the team describes how airborne surveillance systems could be implemented in high human traffic areas such as hospitals, office buildings, airports, and other public meeting places. Such platforms would also complement mass screening methods to help nip potential coronavirus outbreaks in the bud.

Picking up trace amounts of viral pathogens in the air is particularly challenging. This is because of the large air change rate—or how quickly air inside is replaced with outdoor air—in most buildings. For example, air change rates in isolation wards of hospitals range from 8 to 14 times per hour.

To overcome this challenge, the team combined a novel sampling system with ultra-low biomass analysis techniques. Together, these extract all RNA present in air samples.

The isolated RNA is then analyzed using real-time quantitative reverse transcription PCR (RT-qPCR) to identify the presence of a target virus. This assay only requires low levels of detection viral RNA to confirm a positive result, so it is ideal for rapid screening.

The researchers validated their platform in a hospital setting, testing air samples alongside surface swab samples from common areas. They found that the devices that operated at a sampling flow rate of 150 liters per minute enhanced the chances of detecting SARS-CoV-2 compared to the lower flow rates. The air surveillance technique had a high success rate of 72 percent, whereas the surface swabs had a detection rate of only 9.6 percent.

These and other similar technologies can help ensure that people can begin to gather safely while minimizing the risk of COVID-19 infection.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 01, 2021
Health & Medicine
Eppendorf Award 2022: Call for Entries
OCT 01, 2021
Eppendorf Award 2022: Call for Entries
Eppendorf Award 2022: Call for Entries The Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, is ...
OCT 11, 2021
Genetics & Genomics
A Genetic Risk Factor is Shared by Alzheimer's and Severe COVID-19
OCT 11, 2021
A Genetic Risk Factor is Shared by Alzheimer's and Severe COVID-19
While amyloid plaques are a hallmark of Alzheimer's disease, the neurological disorder has also been linked to inflammat ...
OCT 21, 2021
Clinical & Molecular DX
Dementia Diagnostic Looks for 'Hungry' Immune Cells in the Brain
OCT 21, 2021
Dementia Diagnostic Looks for 'Hungry' Immune Cells in the Brain
Experts have long known that the immune cells in our brains called microglia are important for preserving neural tissue ...
NOV 11, 2021
Cancer
US Military Veterans: Cancer Risk and Cancer Research
NOV 11, 2021
US Military Veterans: Cancer Risk and Cancer Research
The US Department of Veteran’s Affairs (VA) estimates about 50,000 new cancer cases diagnosed each year. In total, ...
NOV 23, 2021
Clinical & Molecular DX
Stopping COVID False-Positives From Slipping Through the Cracks
NOV 23, 2021
Stopping COVID False-Positives From Slipping Through the Cracks
False-positive COVID tests results—where the patient isn’t infected but receives a positive result—tri ...
DEC 20, 2021
Genetics & Genomics
UK Biobank Makes 200,000 Human Genomes Publicly Available
DEC 20, 2021
UK Biobank Makes 200,000 Human Genomes Publicly Available
The UK Biobank is an unprecedented resource that has provided researchers with essential data from half a million people ...
Loading Comments...